← Back to briefing

WHO applauds South Africa’s leadership in advancing HIV prevention through lenacapavir rollout

WHO applauds South Africa’s leadership in advancing HIV prevention through lenacapavir rollout
FacebookXWhatsAppEmail

. Launched in Secunda, Mpumalanga province, the introduction of the twice-yearly injectable pre-exposure prophylaxis (PrEP) option demonstrates South Africa’s continued commitment to expanding access to effective, people-centred prevention options. Dr Tedros Adhanom Ghebreyesus, WHO Director-General